Skip to content

ACAD

Acadia Pharmaceuticals Inc.

Revenue to net income

Key figures

MetricLast 12 months5-year CAGR
Revenue$1.2B+19.4%
Gross profit$1.1B+17.9%
Operating income$122M—
Net income$362M—
EPS$2.09—
Free cash flow$82M—